StockNow
Calendar
Log in
U.S. Markets

Bristol Myers Squibb (BMY) spokesperson says the company has identified the cause of an earlier Car-T safety signal; will look to resume the paused trials in 2027

StockNow breaking-news AI analysis

BMS says it identified the cause of an earlier CAR-T safety signal and will look to resume paused trials in 2027, but the supplied item does not state the cause or trial details.

1 stocks
BMYBristol-Myers Squibb Co.$61.53Current price

What do investors think?

Curious what other investors think?Log in to see reactions and join the conversation.
Log in to view reactions

StockNow uses AI to translate and analyze information and does not guarantee its accuracy or completeness.

Today's market highlights

A selection of stories drawing attention in the market.

See more
Geopolitics

While Washington continues to exert economic pressure on Tehran, an American media report says that the US is considering a scenario of several days of attacks on Iran; a scenario that includes missile, drone, energy and nuclear facilities, ILNA reports

Politics

US Treasury Secretary Bessent posts "... the United States is no longer managing the Iranian threat. We are ending it."

U.S. Economy

US S&P Global Services PMI Flash (Oct) 57.9 vs. Exp. 58 (Prev. 58.8)

SPGI